top of page
Search
ipharmaservices
Jun 4, 2019
0
ipharmaservices
Jun 3, 2019
0
ipharmaservices
Jun 1, 2019
0
ipharmaservices
Jun 1, 2019
0
ipharmaservices
May 31, 2019
0
Celgene’s Revlimid in combination with rituximab is indicated for the treatment of previously treate
ipharmaservices
May 29, 2019
0
ipharmaservices
May 26, 2019
0
ipharmaservices
May 24, 2019
0
AbbVie’s cancer product Depatux-M (Depatuxizumab Mafodotin) did not reach the primary endpoint in th
ipharmaservices
May 17, 2019
0
FDA approved Pfizer’s Fragmin for the treatment potentially life-threatening blood clots for pediatr
ipharmaservices
May 16, 2019
0
Celgene’s announced the European Commission approval for Revlimid and Imnovid combination for the tr
ipharmaservices
May 16, 2019
0
ipharmaservices
May 16, 2019
0
AbbVie’s Venclexta get the US FDA approval for chemotherapy free treatment of Chronic Lymphocytic Le
ipharmaservices
May 15, 2019
0
ipharmaservices
May 14, 2019
0
EMA’s CHMP given a positive opinion on Lorviqua for the treatment of previously treated ALK-positive
ipharmaservices
May 9, 2019
0
ipharmaservices
May 8, 2019
0
ipharmaservices
May 7, 2019
0
ipharmaservices
May 6, 2019
0
ipharmaservices
Apr 28, 2019
0
bottom of page